Increased serotonin levels have been reported to be associated with anxiety-like behaviors, and the application of serotonin inhibitor pCPA has indeed ameliorated the excessive locomotor activity observed in nomo1−/− (Pourhamzeh et al, 2022; Evsiukova et al, 2021) (Fig. EV4). The gene discussed is NOMO1; the disease is Anxiety.